Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer

Overview of attention for article published in OncoTargets and therapy, September 2015

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Dove Medical Press, 06 Sep 2015

Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid…